Importance of ''clinical stage'' in the prognosis of patients with DLBCL harboring MYC-R

Hideaki Nitta

Presentation information

Oral Session

Oral Session 1-7B DLBCL: Prognosis and pathology (2)

Fri. Oct 12, 2018 10:10 AM - 11:10 AM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Dai Maruyama (Department of Hematology, National Cancer Center Hospital, Japan)

[OS1-7B-1] Importance of ''clinical stage'' in the prognosis of patients with DLBCL harboring MYC-R

Hideaki Nitta¹, Akihiko Gotoh¹, Masaru Tanaka¹, Norio Komatsu¹, Yasunobu Sekiguchi², Masaaki Noguchi², Yasunori Ota³ (1.Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan, 2.Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan., 3.Department of Pathology, Teikyo University, Tokyo, Japan.)

Abstract password authentication.
Password is written on a program and abstract book.